Lincoln Pharmaceuticals Limited
LINCOLN · NSE · Healthcare
StocksWizard rates Lincoln Pharmaceuticals Limited a Buy, scoring 67/100 on our blended model. At ₹608.75 it trades below our blended DCF and relative-multiples fair value of ₹1,217.5, implying roughly 100% upside to that estimate — we read the stock as undervalued by 100%. Financial health scores 100/100 (grade A), in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. It clears 10 of 13 investability checks, with durability 62, valuation 100 and momentum 49 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹974. Low-confidence estimate — limited data.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%12.3%
- ✓Low debt (D/E < 0.5)0.01x
- ✓Positive free cash flow
- ✓Revenue growth > 10%11%
- ✓Earnings growing1%
- ✓Net margin ≥ 10%13.1%
- ✓Current ratio > 1.55.25
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 7.5
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-18Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 7.5.
Opportunities
- •Trading in our value buy zone versus sector peers.
- •Trades ~100% below our estimated fair value.
About Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada
More in Healthcare
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.